Apologies in advance for the long post... click Next if you

New Post Public Reply Private Reply Replies (2) Message Board
Warp Daveludlow #6219
Apologies in advance for the long post... click Next if you don't want to waste the next 2 minutes of your life. LOL

Dave, the dilution concern you continue to refer to as legitimate is obviously not shared by the majority on this board. We are not the naive investors as you think we are. But your concerns over this issue are starting to sound like the rants of those who believe the moon landings were faked, and are frustrated they can't convince everyone else of the truth of this. Seriously, you need to get a grip. Take your concerns to the company, or sell your shares. Most of the naive investors here understand the dilution concern yet we choose to remain invested and keep our focus on the company and the bright outlook of our future.

So your 1.1 million shares represent hard earned money, do they? What the hell do my shares represent? You have no f*cking idea what you're talking about when you make any attempt to characterize me or my investment style. I take my concerns to the source, not to a public message board where others can do little to nothing about it. Gerald has personally addressed every one of my concerns, and in some cases stated the company would be addressing those concerns in the near future, which they have. I'm satisfied with that. If that's a passive investor, then I suppose I choose to remain a passive investor vs. claiming to be a LT investor yet fretting and losing sleep over every possible outcome in my investment. I feel management has enough challenges ahead of them without me creating more by constantly reminding them of my own insecurities with my investment decision. As Gerald has stated, they are building a world-class biotech company, and if I can't stand the heat of the kitchen, then I should sell my shares and move on. Good advice, in my opinion.

It is not the CEO's job to manage my investment as you claim. It is management's job to manage the company and bring shareholder value, using their knowledge and experience to manage the science and build the best shareholder value they can based on bringing their assets to market. It is my job to manage my investment. It is my job to decide to stick with this investment or not based on my results and how I view the company being managed. It is not my job to try to manage the company, nor attempt to sway investor sentiment to agree with my opinion and put pressure on management to better manage my investment. They are busy running the company. If I had the qualifications to manage the company, I'd be working for them, not simply buying their shares.

You seem to believe I'm wealthy. Again, your analysis here sucks. What is your definition of wealth? And how do you think I came into the money to buy my large position? I'll tell you how. I worked my ass off for years, working 12-hour rotating shifts, and adding 600+ hours annually of overtime for many years. While others were taking off to spend time with family and friends on weekends and holidays, I was at the nuclear plant working. So I would characterize my investment dollars just as hard earned, if not more so, than those you've put into your investment. So how about less talk of your hard-earned dollars? Most here earned the money they invest. Your dollars are no different than anyone else's here.

I can assure you of this... if I only owned 100K or 500K in AMBS shares, my concern over possible dilution ahead would be no different than it is now. I live in reality, not the fantasy world you suggest. The real world would have investors who wouldn't invest in pre-revenue biotech companies if they were concerned about dilution. In the fantasy world, investors invest in such companies often to counter their life-long tendency to borrow for everything, not save enough for retirement, and pin all of their hopes on striking it rich, which is why they fret over everything that "might" happen with their investment, instead of having more trust in management to do what is best both for shareholders and the company.

Let me tell you how I view God in this environment. I pray for Gerald and his team, and those conducting the research to help those in need. I pray that this investment will work out the way God intends, whatever that may be. And I pray God has my best interests in mind, whether that is to provide me with abundant wealth to help others in need, or to teach me a valuable lesson about what many would consider my foolish investment of my limited resources in a risky company like Amarantus.

So, while you are fretting and flipping out over what might happen, I have faith this will all work out as God intended. Gerald is not God. But I believe he is genuinely a good person and may very well be one of God's instruments to help those suffering from these various afflictions. And if I'm blessed to enjoy some rewards as a shareholder, I will certainly do my part in passing on some of those blessings to others in need, as well as my local church to spread God's ministry. If you think that's a "passive" investor, so be it. I imagine my blood pressure and sleep patterns are a lot better than yours. And my faith this will all work according to God's plan gives me comfort. That doesn't mean I don't bring my concerns to the company. One would be a fool to blindly invest and hope it all works out, but we obviously have different levels of faith in this investment.

I'd rather drink Kool-Aid than whatever brew you're drinking. What I'm drinking isn't causing unnecessary concerns over what might happen down the road. You really should watch a specific episode of Deep Space Nine called "Statistical Probabilities" (season 6, episode 9). It is a prime example of your over-analysis of everything Amarantus, and how a single event can change everything and make all of the analysis moot.

Speaking of maturity, it seems to me most here are calm adults who understand the risks. But some seem to be spoiled brats crying for attention and pissed off that everyone else doesn't share their concerns.

One final point... you should work on your reading skills because your mention of my post regarding one of the callers on the recent business update call is way off.

What you posted:
Quote:
Unlike Warp, I thought the gentleman who pressed Gerald on those 5 questions during the CC was right on!! Warp writes off discussion about concerns as anxious "hand wringing" and the cause of "sleepless nights" that only the poor engage in, who really shouldn't be invested in this type of stock in the first place. I thought the gentleman asking the questions on the CC was respectful, but earnest.
What I posted:
Quote:
I sat here listening to these 5 questions and was scratching my head, particularly the ones asking Gerald to reveal any partnerships or asset sales in the works, and when the company expected to be profitable. It's sad this investor took up so much time on the call where other investors could have asked reasonable questions that Gerald might be able to legally answer.

So you believe a reasonable investor question would be for specifics on upcoming sales of the LymPro and Eltoprazine assets, or when the company will reach profitability based on partnership agreements or asset sales currently in the works? You really see those questions as respectful and ernest? What fantasy world are you living in? There's no way Gerald could answer those questions, and not wind up with SEC fines or removal by the BOD as CEO. Respectful and ernest? What kind of shareholder would even ask those questions? One who is out of his league as an investor here and should stick with investing in mutual funds. I'm surprised you feel these were valid questions that should be asked.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CGI Shines with Strong Q4, Announces Dividend Hike

Updated Category News Views 71

CGI Records Impressive Fourth Quarter Growth Well, CGI's got reason to strut its stuff this time around. Clocked in with a fourth-quarter revenue of $4.15 billion - that's a nice 3.3% bump up year-over-year, if you leave the currency noise out of it, it's about 2.5%. The real kicker? Net earnings shot up 20.8%. In a world where everyone’s fighting over scraps, these...

Continue Reading
Florida Parents Push for National Online Safety Deal

Updated Category News Views 62

Florida's Call for Safeguarding Kids Online You know, it's not every day you see a political agreement that can unite parents regardless of which side of the fence they're on, but this one seems to be doing the trick. The call for better online safety measures for kids in Florida is gaining serious muscle, with two-thirds of parents backing the state's participation in a...

Continue Reading
Kroll's Geoeconomic Risk Index: A Financial Sentinel

Updated Category News Views 19

Diving into Kroll's New Geoeconomic Risk Index When global storms brew, businesses yearn for a reliable compass. In swoops Kroll with its Geoeconomic Risk Index—a new tool aimed at taking the mystique out of geopolitical and economic uncertainties to forecast their impact on businesses' bottom lines. Understanding the Index This isn't just another fancy gadget for the...

Continue Reading
Wisconsin Winters: The Art of Navigating Construction Delays

Updated Category News Views 83

Winter's Cold Grasp on Construction Efforts Alright, folks, let's dive into a topic as chilling as a Wisconsin winter itself—those icy weather conditions that builders have to wrangle with each year. You might think snowflakes have got nothing on a solid timeline, but too much snow? That changes the game, my friends. Right off the bat, Kyle Tielens, the know-it-all of...

Continue Reading
National Park Foundation's New Military Outreach Program

Updated Category News Views 50

Bridging the Gap: Parks and Military Communities Fancy title, ain't it? But what truly matters here is how the National Park Foundation (NPF) is setting a new stage for the troops and their families. The spotlight isn't just on faceless numbers; it's on people—those who serve, their loved ones, and the memories they make far from battlefields. Launching this initiative...

Continue Reading
CodeROI Automates AI Cost Tracking for Capitalization

Updated Category News Views 65

Revolutionizing Software Capitalization with CodeROI Forget the good old days when estimating software costs was like pinning the tail on a moving donkey. CodeROI’s latest brainchild brings a sorely needed tune-up, integrating AI development costs into software capitalization. And just in the nick of time, with FASB’s upcoming rule change looming over every tech-savvy...

Continue Reading
ExploitTotal.ai Unleashes Doomsday for Cyber Adversaries

Updated Category News Views 132

Game-Changer in Cybersecurity Once upon a time, building an attack from a patch took the damn patience and skill of a monk. Now? Get ready to welcome ExploitTotal.ai—Anyday Security's free service that arms defenders with AI-built exploits alarmingly fast. We're talking in minutes, not months, from a patch's release. Raising the Cyber Stakes Anyday Security's offering...

Continue Reading
How to Assess a True Christian School Experience

Updated Category News Views 27

Making the Right Spiritual Choice for Your Kids Deciding on a Christian school isn't just about academics or facilities—it’s a spiritual journey that shapes your child's worldview and relationship with God. In Kearney, Nebraska, where strong Christian values are prevalent, Anthony Splittgerber of Zion Lutheran School breaks down for HelloNation how faith-based...

Continue Reading
Webull Faces Class Action Over China Ties Missteps

Updated Category News Views 99

What's Brewing with Webull? Troubling allegations have bubbled to the surface regarding Webull Corporation, now in the crosshairs of a securities class action. The heart of this legal storm is the claim that Webull, under the ticker NASDAQ:BULL, allegedly disguised its deep-seated ties with China. And boy, when those revelations hit the news on October 7, 2026, it sent...

Continue Reading
Oracle's Opower Drives Record Utility Success in 2026

Updated Category News Views 136

Peak Performance: Oracle Opower's Latest Surge Hey, energy watchers, if you don't have Oracle Opower on your radar, it might be time for a check-up! These folks have achieved more peak energy demand reduction this year than you've seen in quite some time. We're talking 1 gigawatt reduced across 70-plus events, no less. Wrap your head around that for a minute! That's like...

Continue Reading

Top 5 Most Recently Viewed Articles

Tyler Technologies CEO's Stock Sale: Impacts and Insights

Updated Category News Views 59

Tyler Technologies and Its Recent Insider Transaction Tyler Technologies Inc. (NYSE: TYL) recently made headlines when its President and CEO, H Lynn Moore Jr., executed a notable stock transaction. Moore sold 5,000 shares of common stock valued at over $2.8 million. This sale was spread out over several trades at different prices. This move showcases Moore's strategic...

Continue Reading
Essential Information for Nextracker Investors to Act Now

Updated Category News Views 293

Key Timeline for Nextracker Investors Investors of Nextracker Inc. must act promptly to file lead plaintiff applications regarding a current class action lawsuit. This lawsuit relates to securities laws violations and encompasses all transactions between specific dates. Understanding the Class Action Lawsuit The ongoing class action lawsuit against Nextracker Inc....

Continue Reading
Addressing the Financial Struggles of China's Auto Dealerships

Updated Category News Views 231

Tackling the Challenges Facing China's Auto Dealers The China Automobile Dealers Association (CADA) recently revealed troubling financial issues impacting car dealerships across the country. Collectively, these dealerships incurred losses of 138 billion yuan, which is about $19.55 billion, over the first eight months of this year. Price Wars Taking a Toll on Dealerships...

Continue Reading
Surging Growth of Wearable Injectors Market, Reaching $8.48 Billion

Updated Category News Views 112

Growth of the Wearable Injectors Market The large volume wearable injectors market is set for remarkable expansion in the upcoming years. With projections estimating a market reach of USD 8,482.4 million by 2035, the industry is expected to witness a significant compound annual growth rate (CAGR) of 8.9%. This promising trajectory is propelled by the increasing demand for...

Continue Reading
Element451 Partners with AWS for Enhanced Educational Engagement

Updated Category News Views 133

Element451 and AWS Collaborate for Student Engagement Enhancement Element451 has announced an official partnership with Amazon Web Services (AWS), marking a significant step in delivering AI-first solutions tailored for higher education institutions. This partnership is aimed at enhancing student experiences while providing robust support to IT leaders striving to...

Continue Reading